Alamar Biosciences, Inc. (ALMR) Revenue, Earnings & Financial Statements
$30.64NASDAQ: ALMRMarket Cap $2.13B
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Alamar Biosciences, Inc. most recently reported annual revenue of $74.0M, a net loss of $30.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Income Statement — 2 Years (USD millions)
Metric
2024
2025
Revenue
—
$74.0M
Operating Expenses
—
$106.0M
Operating Profit
—
−$31.0M
Operating Margin
—
-42.2%
Other Income
—
$2.0M
Interest
$0
$0
Depreciation
—
$4.0M
Profit Before Tax
—
−$29.0M
Tax rate (%)
—
-2.3%
Net Profit
—
−$30.0M
EPS
$—
−$0.45
Quarterly Results — Last 4 Quarters (USD millions)
Metric
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$25.0M
$26.0M
$29.0M
$34.0M
Operating Expenses
$32.0M
$38.0M
$43.0M
$49.0M
Operating Profit
−$7.0M
−$12.0M
−$14.0M
−$15.0M
Operating Margin
-27.9%
-47.4%
-46.0%
-45.1%
Interest
$0
$0
$0
$0
Profit Before Tax
−$7.0M
−$21.0M
−$13.0M
−$13.0M
Tax rate (%)
-3.3%
-2.2%
0.7%
-0.7%
Net Profit
−$7.0M
−$21.0M
−$13.0M
−$13.0M
EPS
−$0.11
−$0.31
−$0.22
−$0.19
Over the 2 years reported for Alamar Biosciences, Inc., borrowings increased from $33.0M in 2024 to $41.0M in 2025, cash stood at $30.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.96 times.
Balance Sheet — 2 Years (USD millions)
Metric
2024
2025
Total Assets
$150.0M
$140.0M
Current Assets
$107.0M
$95.0M
Cash
$27.0M
$30.0M
Inventory
$14.0M
$38.0M
Receivables
$7.0M
$13.0M
Fixed Assets
$35.0M
$37.0M
Capital Work in Progress
$0
$0
Investments
$53.0M
$0
Other Assets
$0
$0
Total Liabilities
$283.0M
$299.0M
Current Liabilities
$17.0M
$24.0M
Borrowings
$33.0M
$41.0M
Other Liabilities
$250.0M
$257.0M
Equity
$0
$0
Reserves
−$133.0M
−$159.0M
For Alamar Biosciences, Inc., free cash flow in the latest year was negative at $60.0M.
Cash Flow Statement — 2 Years (USD millions)
Metric
2024
2025
Operating Cash Flow
—
−$54.0M
Investing Cash Flow
—
$40.0M
Financing Cash Flow
—
−$1.0M
Net Cash Flow
—
$3.0M
Free Cash Flow
$0
−$60.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.23
EV / EBITDA
-40.90
FCF Yield
-3.22%
Quick Ratio
7.87
Interest Coverage
-58.39
Return 1Y
—
Return 3Y
—
Return 5Y
—
Alamar Biosciences, Inc. (ALMR) financials — frequently asked questions
What is Alamar Biosciences, Inc.'s annual revenue?
Alamar Biosciences, Inc. (ALMR) reported annual revenue of $74.0M in its most recent fiscal year.
What is Alamar Biosciences, Inc.'s net profit?
Alamar Biosciences, Inc. (ALMR) reported a net loss of $30.0M in its most recent fiscal year.
What is ALMR EV/EBITDA?
Alamar Biosciences, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -40.90. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Revenue and earnings of other Biotechnology stocks